Iodine,
as a typical haloid element in group VIIA, has been extensively
applied as antiseptics clinically, thanks to its effective and wide-spectrum
antimicrobial activity against bacteria, fungi, and viruses. Nevertheless,
current iodic sterilizing agents are still limited to topical applications
such as instrument sterilization and treatments of skin or mucous
membrane infection due to its unsatisfactory stability and biocompatibility.
Here, we propose an emerging two-dimensional iodine nanomaterial (noted
as iodinene) for the treatment of infection diseases in vivo. Iodinene nanosheets were fabricated by a facile and environmentally
friendly approach via sonication-assisted liquid exfoliation, which
present an intriguing layered structure and negligible toxicity. The
as-synthesized iodinene would experience an in situ allotropic transformation spontaneously to release active HIO and
I2 molecules by reacting with H2O2 in the infectious microenvironment. By the in situ production of active HIO and I2 molecules via allotropic
transformation, iodinene presents enhanced antibacterial efficacy
against Staphylococcus aureus, Escherichia
coli, and Pseudomonas aeruginosa. In vivo outcome demonstrates the desirable antibacterial
efficacy of iodinene in treating bacterial wound infection and pneumonia.
This study thus offers an alternative to conventional sterilizing
agents against hard-to-treat bacterial infections.